Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-28T08:39:43.987Z Has data issue: false hasContentIssue false

23 - Body of the uterus

Published online by Cambridge University Press:  23 December 2009

By
Louise Hanna  and
Malcolm Adams
Edited by
Louise Hanna ,
Tom Crosby  and
Fergus Macbeth
Louise Hanna
Affiliation:
Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
Malcolm Adams
Affiliation:
Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
Louise Hanna
Affiliation:
Velindre Hospital, Cardiff
Tom Crosby
Affiliation:
Velindre Hospital, Cardiff
Fergus Macbeth
Affiliation:
Velindre Hospital, Cardiff
Get access

Summary

Introduction

The most common tumour affecting the body of the uterus is endometrial adenocarcinoma. The major risk factor for disease is unopposed oestrogen stimulation of the endometrium, which is associated with obesity; because of this, endometrial cancer is more common among women in developed countries. Most patients present with stage I disease and have a good prognosis when treated with a combination of surgery and selective postoperative radiotherapy. Other tumours affecting the body of the uterus include the uterine sarcomas, a group of tumours that may arise from the endometrium or the myometrium. These are aggressive tumours but treatment may be curative for early stage disease.

Gestational trophoblastic tumours are discussed in Chapter 27.

Types of tumour affecting the uterus

Approximately 90% of endometrial cancers are carcinomas, and approximately 90% of these are adenocarcinomas. Types of uterine tumour are shown in Table 23.1.

Incidence and epidemiology

The annual incidence of uterine cancer is 14.9 in 100,000 (CRUK National Statistics; see info.cancerresearchuk.org, accessed September, 2006). In 2002 there were 5600 new cases of uterine cancer diagnosed in the UK. Uterine cancer accounts for 4% of all female malignancies. The disease is more common in the Western world than in developing countries and more common in women with high socioeconomic status and nulliparity. The high incidence has been linked with increasing levels of obesity and physical inactivity (Schouten et al., 2004). Endometrial carcinoma occurs typically in the postmenopausal age group, and the median age is 60 years.

Type
Chapter
Information
Practical Clinical Oncology , pp. 267 - 277
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aalders, J., Abeler, V., Kolstad, P.et al. (1980). Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathological study of 540 patients. Obstet. Gynecol., 56, 419–27.Google Scholar
Abeler, V. M. and Kjorstad, K. E. (1991). Endometrial adenocarcinoma in Norway. A study of a total population. Cancer, 67, 3093–103.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Akram, T., Maseelall, P. and Fanning, J. (2005). Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Am. J. Obstet. Gynecol., 192, 1365–7.CrossRefGoogle ScholarPubMed
Amant, F., Cadron, I., Fuso, L.et al. (2005a). Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol. Oncol., 98, 274–80.CrossRefGoogle Scholar
Amant, F., Moerman, P., Neven, P.et al. (2005b). Endometrial cancer. Lancet, 366, 491–505.CrossRefGoogle Scholar
Ambros, R. A., Sherman, M. E., Zahn, C. M.et al. (1995). Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumours displaying serous differentiation. Human Pathol., 26, 1260–7.CrossRefGoogle ScholarPubMed
Aoki, Y., Watanabe, M., Amikura, T.et al. (2004). Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. Gynecol. Oncol., 94, 333–9.CrossRefGoogle Scholar
Benedet, J. L., Bender, H., Jones, H. 3rdet al. (2000). Federation Internationale de Gynecologie et d'Obstetrique staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int. J. Gynecol. Obstet., 70, 209–62.Google Scholar
Board of the Faculty of Clinical Oncology, The Royal College of Radiologists. (2006). Radiotherapy Dose-Fractionation. London: Royal College of Radiologists, p. 36.
Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol., 15, 10–17.CrossRefGoogle ScholarPubMed
Creutzberg, C. L., Putten, W. L., Koper, P. C.et al. (2000). Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet, 355, 1404–11.CrossRefGoogle ScholarPubMed
Creutzberg, C. L., Putten, W. L., Koper, P. C.et al. (2003). Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol. Oncol., 89, 201–9.CrossRefGoogle ScholarPubMed
Dhar, K. K., NeedhiRajan, T., Koslowski, M.et al. (2005). Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol. Oncol., 97, 924–7.CrossRefGoogle ScholarPubMed
Eifel, P., Hendrickson, M., Ross, J.et al. (1982). Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer, 50, 163–70.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
European Society for Therapeutic Radiology and Oncology. (2002). The GEC European Society for Therapeutic Radiology and Oncology Handbook of Brachytherapy, ed. Gerbaulet, A., Potter, R., Mazeron, J.-J.et al.Brussels: European Society for Therapeutic Radiology and Oncology, Chap. 15, pp. 365–401.Google Scholar
Faithfull, S. and Wells, M. (2003). Supportive Care in Radiotherapy. London: Churchill Livingstone.Google Scholar
Federation Internationale de Gynecologie et d'Obstetrique. (1994). Federation Internationale de Gynecologie et d'Obstetrique Annual Report on the Results of Treatment in Gynaecologic Cancer: Cancer of the Corpus Uteri 13040 Patients Treated 1987–1989, ed. Pettersson, F.. Stockholm, Sweden, 22, 169–99.Google Scholar
Gredmark, T., Kvint, S., Havel, G.et al. (1995). Histopathological findings in women with postmenopausal bleeding. Br. J. Obstet. Gynaecol., 102, 133–6.CrossRefGoogle ScholarPubMed
Gupta, J. K., Chien, P. F., Voit, D.et al. (2002). Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet. Gynecol. Scand., 81, 799–816.CrossRefGoogle ScholarPubMed
Holloway, R. W. (2003). Treatment options for endometrial cancer: experience with topotecan. Gynecol. Oncol., 90, S28–33.CrossRefGoogle ScholarPubMed
Hornback, N. B., Omura, G. and Major, F. J. (1986). Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int. J. Radiat. Oncol. Biol. Phys., 12, 2127–30.CrossRefGoogle Scholar
Kanjeekal, S., Chambers, A., Fung, M. F.et al. (2005). Systemic therapy for advanced uterine sarcomas: a systematic review of the literature. Gynecol. Oncol., 97, 624–37.CrossRefGoogle ScholarPubMed
Keys, H. M., Roberts, J. A., Brunetto, V. L.et al. (2004). A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92, 744–51.CrossRefGoogle ScholarPubMed
Kieser, K. and Oza, A. M. (2005). What's new in systemic therapy for endometrial cancer. Curr. Opin. Oncol., 17, 500–4.CrossRefGoogle ScholarPubMed
Kim, S. H., Kim, H. D., Song, Y. S.et al. (1995). Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, computed tomography and magnetic resonance imaging. J. Comput. Assist. Tomogr., 19, 766–72.CrossRefGoogle Scholar
Kurman, R. J., Kaminski, P. F. and Norris, H. J. (1985). The behaviour of endometrial hyperplasia. A long-term study of ‘untreated’ hyperplasia in 170 patients. Cancer, 56, 403–12.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Lai, C. H. and Huang, H. J. (2006). The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer. Curr. Opin. Obstet. Gynecol., 18, 29–34.Google ScholarPubMed
Livi, L., Andreopoulou, E., Shah, N.et al. (2004). Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1988. Clin. Oncol. (R. Coll. Radiol.), 16, 261–8.CrossRefGoogle Scholar
Martin-Hirsch, P. L., Lilford, R. J. and Jarvis, G. J. (1996). Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analysis of published randomised controlled trials. Eur. J. Obstet. Gynecol. Reprod. Biol., 65, 201–7.CrossRefGoogle ScholarPubMed
Michener, C. M., Peterson, G., Kulp, B.et al. (2005). Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma. J. Cancer Res. Clin. Oncol., 131, 581–4.CrossRefGoogle ScholarPubMed
Montz, F. J., Bristow, R. E., Bovicelli, A.et al. (2002). Intrauterine progesterone treatment of early endometrial cancer. Am. J. Obstet. Gynecol., 186, 651–7.CrossRefGoogle ScholarPubMed
Niwa, K., Tagami, K., Lian, Z.et al. (2005). Outcome of fertility-preserving treatment in young women with endometrial carcinomas. Br. J. Obstet. Gynecol., 112, 317–20.CrossRefGoogle ScholarPubMed
Nordal, R. N., Kjorstad, K. E., Stenwigh, A. E.et al. (1993). Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985. Int. J. Gynecol. Cancer, 3, 110–15.CrossRefGoogle ScholarPubMed
Ramirez, P. T., Frumovitz, M., Bodurka, D. C.et al. (2004). Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol. Oncol., 95, 133–8.CrossRefGoogle ScholarPubMed
Schouten, L. J., Goldbohm, R. A. and Brandt, P. A. (2004). Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J. Natl. Cancer. Inst., 96, 1635–8.CrossRefGoogle ScholarPubMed
Tozzi, R., Malur, S., Koehler, C.et al. (2005). Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J. Minim. Invasive Gynecol., 12, 130–6.CrossRefGoogle ScholarPubMed
World Health Organisation classification. (2003). In World Health Organization Classification of Tumours: Pathology and genetics of tumours of the breast and female genital organs, ed. Tavassoli, A. and Devilee, P.. Lyon: IARC Press, Chap. 4.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Body of the uterus
    • By Louise Hanna, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK, Malcolm Adams, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
  • Edited by Louise Hanna, Tom Crosby, Fergus Macbeth
  • Book: Practical Clinical Oncology
  • Online publication: 23 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545375.024
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Body of the uterus
    • By Louise Hanna, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK, Malcolm Adams, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
  • Edited by Louise Hanna, Tom Crosby, Fergus Macbeth
  • Book: Practical Clinical Oncology
  • Online publication: 23 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545375.024
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Body of the uterus
    • By Louise Hanna, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK, Malcolm Adams, Consultant, Clinical Oncologist, Velindre Cancer Centre, Velindre Hospital, Whitchurch, Cardiff, UK
  • Edited by Louise Hanna, Tom Crosby, Fergus Macbeth
  • Book: Practical Clinical Oncology
  • Online publication: 23 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545375.024
Available formats
×